Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8498815rdf:typepubmed:Citationlld:pubmed
pubmed-article:8498815lifeskim:mentionsumls-concept:C0175677lld:lifeskim
pubmed-article:8498815lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:8498815lifeskim:mentionsumls-concept:C0085140lld:lifeskim
pubmed-article:8498815lifeskim:mentionsumls-concept:C0178601lld:lifeskim
pubmed-article:8498815lifeskim:mentionsumls-concept:C0233795lld:lifeskim
pubmed-article:8498815pubmed:issue3lld:pubmed
pubmed-article:8498815pubmed:dateCreated1993-6-24lld:pubmed
pubmed-article:8498815pubmed:abstractTextWe studied the persistent antegrade memory impairment in a woman whose brain had been surgically impaled, leaving a 1-cm-wide mediobasal tract of encephalomalacia that extended just anterior to the septal nuclei and medial to the nucleus accumbens. In a blinded, controlled, alternating repeated-measures protocol, bromocriptine significantly improved her verbal learning, functional memory, and daily recall, perhaps by acting on neurons that had been disconnected from the ventral tegmental tract's dopaminergic inputs.lld:pubmed
pubmed-article:8498815pubmed:languageenglld:pubmed
pubmed-article:8498815pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8498815pubmed:citationSubsetIMlld:pubmed
pubmed-article:8498815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8498815pubmed:statusMEDLINElld:pubmed
pubmed-article:8498815pubmed:monthMarlld:pubmed
pubmed-article:8498815pubmed:issn0364-5134lld:pubmed
pubmed-article:8498815pubmed:authorpubmed-author:DobkinB HBHlld:pubmed
pubmed-article:8498815pubmed:authorpubmed-author:HanlonRRlld:pubmed
pubmed-article:8498815pubmed:issnTypePrintlld:pubmed
pubmed-article:8498815pubmed:volume33lld:pubmed
pubmed-article:8498815pubmed:ownerNLMlld:pubmed
pubmed-article:8498815pubmed:authorsCompleteYlld:pubmed
pubmed-article:8498815pubmed:pagination313-6lld:pubmed
pubmed-article:8498815pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8498815pubmed:meshHeadingpubmed-meshheading:8498815-...lld:pubmed
pubmed-article:8498815pubmed:meshHeadingpubmed-meshheading:8498815-...lld:pubmed
pubmed-article:8498815pubmed:meshHeadingpubmed-meshheading:8498815-...lld:pubmed
pubmed-article:8498815pubmed:meshHeadingpubmed-meshheading:8498815-...lld:pubmed
pubmed-article:8498815pubmed:meshHeadingpubmed-meshheading:8498815-...lld:pubmed
pubmed-article:8498815pubmed:meshHeadingpubmed-meshheading:8498815-...lld:pubmed
pubmed-article:8498815pubmed:meshHeadingpubmed-meshheading:8498815-...lld:pubmed
pubmed-article:8498815pubmed:meshHeadingpubmed-meshheading:8498815-...lld:pubmed
pubmed-article:8498815pubmed:meshHeadingpubmed-meshheading:8498815-...lld:pubmed
pubmed-article:8498815pubmed:year1993lld:pubmed
pubmed-article:8498815pubmed:articleTitleDopamine agonist treatment of antegrade amnesia from a mediobasal forebrain injury.lld:pubmed
pubmed-article:8498815pubmed:affiliationSchool of Medicine, Department of Neurology, University of California, Los Angeles 90024-6975.lld:pubmed
pubmed-article:8498815pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8498815pubmed:publicationTypeCase Reportslld:pubmed